Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 3:13 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2785–2808 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Sleep Disorder, Circadian Dysregulation
Interventions: Trans-C for sleep and circadian function + Memory Support; Behavioral
Lead sponsor: University of California, Berkeley; Other
Eligibility: 55 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Traumatic Brain Injury
Interventions: MedX Health Phototherapy (light therapy); Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-Associated Steatohepatitis (MASH), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions: Miricorilant; Drug
Lead sponsor: Corcept Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Chronic Granulomatous Disease
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 3 Years and older
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mild Cognitive Impairment, Prodromal Alzheimer's Disease
Interventions: Placebo Oral Tablet, AGB101 220 mg tablet; Drug
Lead sponsor: AgeneBio; Industry
Eligibility: 55 Years to 85 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 23
States / cities: Phoenix, Arizona • Laguna Hills, California • Oceanside, California + 20 more

Conditions: Schizophrenia
Interventions: Placebo, Luvadaxistat; Drug
Lead sponsor: Neurocrine Biosciences; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 33
States / cities: Phoenix, Arizona • Bentonville, Arkansas • Bryant, Arkansas + 24 more

Conditions: Alzheimer Disease (AD), Cardio Vascular Disease, Mild Cognitive Impairment (MCI), Frailty Syndrome, Disability Physical, Hypertension, Metabolic Syndrome (MetS), Healthy Aging, Obesity &Amp; Overweight
Interventions: Not listed
Lead sponsor: Marymount University; Other
Eligibility: 50 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Arlington, Virginia

Conditions: Cognition, Cancer
Interventions: Emerging from the Haze; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Right Ventricular Dysfunction
Interventions: 3D TEE RVEF; Diagnostic Test
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Sacroiliac Joint Dysfunction, Sacroiliac Joint Pain
Interventions: Bone Allograft; Other
Lead sponsor: PainTEQ, LLC; Industry
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Impairment, Cognitive, Impairment of Attention, Impairment, Psychomotor
Interventions: Delta-9-THC, Delta-8-THC, Placebo; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 49 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Mild Cognitive Impairment
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Duke University; Other
Eligibility: 60 Years to 82 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Postoperative Cognitive Dysfunction
Interventions: Neurocognitive Testing; Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 50 Years to 99 Years
Enrollment: 57 participants
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Alzheimer's Disease
Interventions: Riluzole, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 50 Years to 95 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 2
States / cities: New York, New York

Conditions: Inflammation, Endothelial Dysfunction
Interventions: CEAG, placebo; Dietary Supplement
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Torrance, California

Conditions: Breast Cancer, HER2-positive Breast Cancer, HER2-positive Metastatic Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Breast Cancer Stage IV, Cardiotoxicity
Interventions: Cardiopulmonary Exercise Test, Echocardiogram, Echocardiography; Diagnostic Test
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Sexual Dysfunction
Interventions: Abilify Maintena; Drug
Lead sponsor: Gazda, Thomas D., M.D., PC; Individual
Eligibility: 18 Years to 40 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Bullhead City, Arizona

Conditions: Mild Cognitive Impairment, Mild Dementia, Parkinson Disease, Lewy Body Disease
Interventions: Placebo Oral Capsule, NYX-458; Drug
Lead sponsor: Aptinyx; Industry
Eligibility: 50 Years to 80 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 26
States / cities: Scottsdale, Arizona • Fresno, California • Simi Valley, California + 20 more

Conditions: Mild Cognitive Impairment (MCI), Mild Alzheimer Disease, Memory Deficits
Interventions: home-based self-administered interactive exercise; Device
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 50 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Intradialytic Hypertension
Interventions: Carvedilol vs. Prazosin; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Functional Impairment, Cognitive Impairment
Interventions: iHI-FIVES; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 1,406 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Voiding Dysfunction
Interventions: Not listed
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Cognitive Disorder
Interventions: SUVN-D4010; Drug
Lead sponsor: Suven Life Sciences Limited; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Lenexa, Kansas

Conditions: Congestive Heart Failure (CHF), Systolic Dysfunction
Interventions: Nurse-management; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 406 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2002
U.S. locations: 4
States / cities: New York, New York

Search by objective public record fields.

Improving Well-being by Improving Memory for Treatment for Sleep and Circadian Dysfunction

Effects of LEDs on Memory in TBI Patients

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995

Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease

Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia

Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

Emerging From the Haze™- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment

TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR

Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion

High Confusion: Cannabis & Driving

Network-guided TMS in Early Alzheimer's Disease

Prognostic Factors Associated With Postoperative Cognitive Dysfunction After Surgery

Riluzole in Mild Alzheimer's Disease

Effect of CEAG on Inflammation and Endothelial Function

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)

Self-Administered Interactive Exercise Program (Tele-Exergame)

Mechanisms of Increased Ambulatory Blood Pressure in Patients With Intradialytic Hypertension

Optimizing Function and Independence Through iHI-FIVES

Outcomes of Pudendal InterStim

A Study to Investigate the Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-D4010 in Healthy Subjects

Improving Heart Failure Care in Minority Communities